Skip to main content
logo
Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.460
-0.110 (-7.01%)
At close: Mar 13, 2026, 4:00 PM EDT
1.470
+0.010 (0.68%)
After-hours: Mar 13, 2026, 4:44 PM EDT

Metagenomi Therapeutics Revenue

In the year 2025, Metagenomi Therapeutics had annual revenue of $25.21M, down -51.79%. Metagenomi Therapeutics had revenue of $3.91M in the quarter ending December 31, 2025, a decrease of -59.32%.

Revenue (ttm)
$25.21M
Revenue Growth
-51.79%
P/S Ratio
2.18
Revenue / Employee
$203,306
Employees
124
Market Cap
54.93M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202525.21M-27.09M-51.79%
Dec 31, 202452.30M7.54M16.84%
Dec 31, 202344.76M27.56M160.21%
Dec 31, 202217.20M16.96M6,978.19%
Dec 31, 2021243.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ImmuCell27.64M
MindWalk Holdings19.02M
Alterity Therapeutics4.43M
Lipocine1.98M
Mereo BioPharma Group500.00K
Entera Bio124.00K
Impact BioMedical32.00K
eXoZymes-700.00
Revenue Rankings

MGX News

More News